Vanguard files Schedule 13G/A showing 0% in DHC
The Vanguard Group filed Amendment No. 2 on a Schedule 13G/A reporting its position in Diversified Healthcare Trust common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 2 on a Schedule 13G/A reporting its position in Diversified Healthcare Trust common stock. The filing states amount beneficially owned: 0 shares representing 0%. The filing explains an internal realignment on January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report beneficial ownership separately. The disclosure is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Insights
Vanguard reports no beneficial ownership after internal disaggregation.
The Vanguard Group states it holds 0 shares of Diversified Healthcare Trust common stock, 0%, in this Amendment No. 2 filing. The form attributes the change to an internal realignment on January 12, 2026 under SEC Release No. 34-39538; certain subsidiaries now report separately.
These filings document reporting structure, not an economic transfer of securities. Cash‑flow treatment and trading activity are not disclosed in the provided excerpt; subsequent filings would show any holder-level transactions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does The Vanguard Group report in DHC?
Why did Vanguard change how it reports ownership in DHC?
Who signed the Schedule 13G/A amendment for Vanguard?
Is Vanguard reporting any person with >5% ownership of DHC here?
AI-generated analysis. How Rhea-AI works. Not financial advice.